Prostatic carcinoma

Posted on

Q) Origin of prostatic carcinoma is from which zone 
A. Transition zone
B. Peripheral zone
C. Central zone


NSGCT management

Posted on

Q)  NSGCT post BEP, Residual Retroperitoneal mass of 2 cm. What will be the further treatment.
A. Observe
B. Complete RPLND
C. Two cycles of BEP
D. Radiotherapy

Prognostic features of NSGCT

Posted on

Q) Poor prognostic feature for NSGCT (Non Seminomatous germ cell tumor) 
A. Age more than 40 years
B. Mediastinal tumour
C. AFP level less  than 10,000
D. Non Pulmonary visceral metastasis absent

Staging Carcinoma Penis

Posted on

Q) Carcinoma Penis invading into the Corpora Spongiosum is ?

a) T1a

b) T1b

c) T2

d) T3

Bladder Cancer

Posted on

Q) What is the most suitable treatment option for non muscle-invasive bladder cancer with the risk of recurrences?


B)Intravesical chemotherapy

C)Transurethral resection and adjuvant intravesical chemotherapy

D)Palliative therapy


Patients with non–muscle-invasive bladder cancer (confined to the bladder mucosa or submucosa) can be managed with transurethral resection alone and adjuvant intravesical (instilled into the bladder) chemotherapy/immunotherapy.

The use of these intravesical agents is critical since patients with non–muscle-invasive bladder cancer are at risk for tumour recurrence and progression.


Uro Onco MCQS

VON Hipple

Posted on

Q)Von Hippel Lindau (VHL) causes all except
1. breast cancer
2. pancreas cancer
3. renal
4. hemangioma of cerebellum